サルコメア変異の微細構造および微細血管現象 媒介者および露骨な高縮性心筋病
George Joy1,2, Christopher I Kelly3, Matthew Webber2,4,5
1Barts Heart Centre, Barts Health NHS Trust, London, UK (G.J., I.P., P.V., R.K.H., H.K., A.B., M.L., K.S., S.A.M., M.O., C.M., R.H.D., P.D.L., J.C.M., L.R.L.).
Circulation
|July 18, 2023
まとめ
筋細胞の乱れとマイクロ血管疾患 (MVD) は,高縮性心筋病 (HCM) の初期指標である. これらの変化は,過剰増殖なしでも検出され,病気を修正する治療法の重要なバイオマーカーとして機能します.
科学分野:
- 心臓病科
- バイオマーカー
- 医療用イメージング
背景:
- ハイパルトロフィック心筋病 (HCM) は,潜在的に早期に発生する,筋細胞の乱れとマイクロ血管疾患 (MVD) に関連しています.
- 早期のフェノタイプ発現を検出することは,新しい病気を修正する治療法にとって極めて重要です.
研究 の 目的:
- 心筋の微細構造とMVDをHCMにおける早期の,疾患特有のバイオマーカーとして評価する.
- これらのバイオマーカーを顕在 (遺伝子型陽性/陰性) と亜臨床 HCM で評価する.
- 微細構造,MVD,電気的変化,遺伝的要因との関係を調査する.
主な方法:
- 206人の被験者による多センター研究:明白なHCM (G+LVH+,G-LVH+),亜臨床的HCM (G+LVH-),および健康なボランティア.
- 12線心電図,定量 perfusion 心筋MRI,心筋拡散テンサー画像 (DTI) を利用した.
- DTIパラメータは,微分アニソトロピー,平均拡散度,および微細構造を評価する第二自ベクトル角度を測定した.
主要な成果:
- Overt HCMの患者は,対照群と比較して,微細構造とMVDが有意に変化した.
- サブクリニック HCM (G+LVH-) も,早期の変化を示す変化した微細構造とMVDを示した.
- 肌細胞の乱れとMVDは,公然と亜臨床的なHCMの両方で異常なECG発見と独立して関連していました.
結論:
- 顕在のHCMでは微小構造的変異とMVDが存在し,遺伝子型陽性と陰性患者の間で異なっている.
- これらの変化は,突然変異の媒介者において高縮性がない場合でも起こり,ECGの異常と相関する.
- 心筋の微細構造とMVDは 初期フェノタイプのバイオマーカーとして機能し 病気を改変する治療法の時代に不可欠です
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy I: Introduction and Classification
18
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
18
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Structure of Cardiac Muscles
13.2K
Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
13.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16


